Kolmar Korea, a prominent player in the cosmetics and personal care industry, has made a groundbreaking stride in the realm of hair loss mitigation. Their recent revelation regarding the efficacy of Sophora flavescens extract in combatting hair loss has not only been unveiled but has also marked the initiation of the industry’s maiden patent application in this domain. This significant breakthrough has swiftly garnered widespread international attention.
The announcement, made on April 18th, transpired at the esteemed World Congress for Hair Research (WCHR) held in Dallas, Texas. Kolmar Korea showcased their extensive research findings on Sophora flavescens root extract, elucidating its pivotal role as a functional ingredient for alleviating hair loss. The WCHR, now in its 13th year, stands as a pinnacle of authority in matters concerning scalp and hair loss treatment on a global scale.
Traditionally renowned for its diverse medicinal properties including digestive health, anti-inflammatory attributes, and anti-cancer potentials, Sophora flavescens, a legume indigenous to Korea, has now emerged as a potent candidate for hair loss mitigation under Kolmar Korea’s scientific scrutiny. This heralds a significant stride for the company as they venture into uncharted territory with their patent application.
Kolmar Korea has substantiated through rigorous research that Sophora flavescens root extract not only fortifies hair roots but also stimulates hair growth. Furthermore, their findings unveil its capability to mitigate stress-induced and particulate matter-induced hair loss by suppressing the expression of pertinent genes. An added advantage lies in its natural composition, which significantly reduces skin irritation when compared to synthetic alternatives commonly employed in hair loss treatments.
With a strategic vision in mind, Kolmar Korea intends to capitalize on these groundbreaking findings by developing a range of premium hair loss cosmetics. These forthcoming products are poised to cater not only to the needs of adult men and women but also to the more sensitive demographics such as pregnant women and infants who are prone to skin irritation.
A spokesperson for Kolmar Korea affirmed, “With the burgeoning global demand for hair loss solutions, particularly in the premium segment, we are committed to expediting our research and development endeavors in this realm, leveraging the potential of Sophora flavescens root extract and other innovative technologies.”
In a concurrent pursuit of innovation, Kolmar Korea has pioneered the integration of microbiome technology into the arena of hair loss treatment. Their recent breakthrough involves the development of “biome-scented” ingredients adept at thwarting hair loss-causing bacteria while fostering a harmonious scalp ecosystem. This groundbreaking innovation has earned Kolmar Korea the distinction of being the first in the world to introduce such technology, bolstered by patent filings in three countries.
Furthermore, Kolmar Korea has augmented their technological repertoire by devising methodologies to enhance the precision of hair loss diagnostics through biome technology. In a noteworthy development, the company secured patents in December of the preceding year pertaining to scalp microbiome-based biomarkers for diagnosing hair loss in both men and women. These biomarkers harness various biological indicators such as proteins, DNA, RNA, and metabolic substances to discern subtle changes within the body indicative of hair loss.
